Revisiting Cationic Phosphorus Dendrimers as a Nonviral Vector for Optimized Gene Delivery Toward Cancer Therapy Applications
Authors:
- 29 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 21 (6) , 2502-2511
Abstract
Gene delivery, one important cancer therapy mode, still remains to be challenging due to the shortage of highly efficient and safe non-viral vectors. Here, we revisit the development of cationic phosphorus dendrimers by synthesizing them with different generations (G1-3) and surface ligands (1-(2-aminoethyl) pyrrolidine, 1-(3-aminopropyl) piperidine, or 1-(2-aminoethyl) piperidine) for optimized gene delivery toward cancer gene therapy applications. First, the synthesized dendrimer derivatives were employed to condense plasmid DNA (pDNA) encoding enhanced green fluorescent protein (EGFP) to optimize their gene delivery efficiency by varying the dendrimer generations and surface polycationic ligands. We show that all dendrimer/pDNA polyplexes display good cytocompatibility, and the 1-(2-aminoethyl) pyrrolidine-modified protonated G1 dendrimers (1-G1) display the best gene delivery efficiency to HeLa cells under the same conditions through flow cytometry and fluorescence microscopic imaging analyses. Hence, 1-G1 dendrimers were then used as a vector to transfect pDNA encoding both EGFP and p53 protein for cancer gene therapy applications. Our results reveal that under the optimized conditions, the transfection of pDNA induces the significant p53 protein expression as verified through the resulted cell cycle arrest (regulation of p21 and Cdk4/Cyclin-D1 expression) and Western blotting. The cancer gene therapy potential of the polyplexes was finally validated through therapy of a xenografted tumor model after intratumoral injection without systemic toxicity. The developed cationic 1-G1 dendrimers may be adopted as a powerful vector system for gene therapy of cancer, as well as for highly effective gene therapy of other diseases.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2017YFE0196200)
- Centre National de la Recherche Scientifique
- Science and Technology Commission of Shanghai Municipality (18520750400, 19XD1400100)
- National Natural Science Foundation of China (21773026, 21911530230, 81761148028)
- Sino-French Cai Yuanpei Programme
This publication has 58 references indexed in Scilit:
- Delivery of Antisense Oligonucleotides and Plasmid DNA with Various Carrier AgentsAntisense and Nucleic Acid Drug Development, 1999
- Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimersNucleic Acids Research, 1996
- In Vitro Gene Delivery by Degraded Polyamidoamine DendrimersBioconjugate Chemistry, 1996
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Inhibition of Interleukin-1-Induced Effects in Synoviocytes Transduced with the Human IL-1 Receptor Antagonist cDNA Using an Adenoviral VectorHuman Gene Therapy, 1995
- Overexpression of Human Methylmalonyl CoA Mutase in Mice after In Vivo Gene Transfer with Asialoglycoprotein/Polylysine/DNA ComplexesHuman Gene Therapy, 1994
- High-Efficiency Gene Transfer Mediated by Adenovirus-Polylysine-DNA ComplexesAnnals of the New York Academy of Sciences, 1994
- Non-viral approaches to gene therapyCurrent Opinion in Biotechnology, 1993
- Polyamidoamine cascade polymers mediate efficient transfection of cells in cultureBioconjugate Chemistry, 1993
- Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells.Proceedings of the National Academy of Sciences, 1991